Finance

Mga Listahan
ZTS:NYSE
Zoetis Inc
$74.47
-1.56%
(-1.18) 1D
Okt 13, 3:27:03 PM GMT-4  ·   USD
Lahat ng simbolo
SimboloPresyoPalitan% ng Pagbabago
Bumubuo ng mga nangungunang insight para sa ZTS...
Buksan
$75.98
Mataas
$75.99
Mababa
$74.48
Mkt. cap
30.81B
Avg. na dami
4.52M
Dami
1.40M
Dividend
2.85%
Bawat tatlong buwang dividend
$0.53
Petsa ng ex-dividend
Hul 20, 2026
P/E ratio
12.25
Mataas nang 52-wk
$148.30
Mababa nang 52-wk
$68.77
EPS
$6.08
Beta
0.74
Mga natitirang share
413.22M
Bilang ng mga empleyado
14K
Buksan
$75.98
Mataas
$75.99
Mababa
$74.48
Mkt. cap
30.81B
Avg. na dami
4.52M
Dami
1.40M
Dividend
2.85%
Bawat tatlong buwang dividend
$0.53
Petsa ng ex-dividend
Hul 20, 2026
P/E ratio
12.25
Mataas nang 52-wk
$148.30
Mababa nang 52-wk
$68.77
EPS
$6.08
Beta
0.74
Mga natitirang share
413.22M
Bilang ng mga empleyado
14K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Profile
Zoetis Inc., headquartered in Parsippany, New Jersey, is the largest producer of medicine and vaccinations for pets and livestock worldwide. The company's products include antiparasitics, vaccines, products that relieve itch, anti-infectives, products that alleviate pain, animal health diagnostics, as well as hormones, cardiopulmonary, topical and oral hygiene therapeutics, central nervous system drugs, diuretics, antiemetic, euthanasia, and hepato-digestive products. The company has operations in over 50 countries. In 2025, 70% of the company's revenue came from products for pets and 29% of the company's revenues came from products for livestock. In 2025, 54% of the company's revenue came from customers in the United States. Of this revenue, 79% came from products for dogs and cats, 13% came from products for cattle, and 4% came from products for horses. In 2025, 46% of the company's revenue came from international customers. Of this revenue, 53% came from products for dogs and cats, 19% came from products for cattle, 9% came from products for swine, 7% came from products for poultry, and 3% came from products for horses. Wikipedia
Tungkol sa Zoetis Inc
CEOKristin C. Peck
Mga Empleyado14.5K
Itinatag1952
HeadquartersParsippany-Troy Hills, New Jersey, Estados Unidos
Sektor-
Websitezoetis.com
Mga rating ng analyst
Batay sa 11 (na) analyst na nagbigay ng mga rating ng stock sa ZTS sa nakalipas na 3 buwan
Pagbili
Pagbili
4
Pag-hold
7
Pagbebenta
0
12 buwang forecas
Batay sa 11 (na) analyst sa Wall Street na nag-aalok ng mga target na presyo sa loob ng 12 buwan para sa ZTS sa nakalipas na 3 buwan.
Pinakamataas
Kasalukuyan $74.47
$115.00 (+54.42%)
Average
$90.71 (+21.81%)
Pinakamababa
$80.00 (+7.43%)
Analyst
Rekomendasyon
Aksyon
Target na presyo
Inaasahan
Petsa
Daniel Clark
Leerink Partners
Hold
Reiterated
-
-
10/01/2026
Jonathan Block
Stifel Nicolaus
Hold
Reiterated
-
-
09/18/2026
Steve Scala
TD Cowen
Buy
Reiterated
$94.00
+26.2%
08/25/2026
Glen Santangelo
Barclays
Hold
Reiterated
$85.00
+14.1%
08/17/2026
Chris Schott
J.P. Morgan
Buy
Maintained
$115.00
+54.4%
08/10/2026
Daniel Grosslight
Citi
Buy
Maintained
$96.00
+28.9%
08/11/2026
David Westenberg
Piper Sandler
Hold
Maintained
$80.00
+7.4%
08/10/2026
Erin Wright
Morgan Stanley
Buy
Reiterated
$85.00
+14.1%
08/10/2026
Andrea Alfonso
UBS
Hold
Reiterated
$80.00
+7.4%
08/07/2026
Ryan Daniels
William Blair
Hold
Downgraded
-
-
08/06/2026
Brandon Vazquez
William Blair
Hold
Downgraded
-
-
08/08/2026
Michael Ryskin
Bank of America Securities
Hold
Maintained
-
-
07/28/2026
Sidharth Sahoo
HSBC
Buy
Maintained
$95.00
+27.6%
07/06/2026
Jasper Hellweg
Argus Research
Hold
Downgraded
-
-
05/26/2026
Scott Schoenhaus
KeyBanc
Hold
Maintained
-
-
05/08/2026
Thomas DeBourcy
Nephron
Hold
Downgraded
$131.00
+75.9%
03/05/2026
Mark Massaro
BTIG
Buy
Reiterated
$160.00
+114.9%
02/26/2026
Huling ulat
Ago 6, 2026
Fiscal period
Q2 2026
$1.87 / $1.85
+0.95%lumampas
Kita / Pagtataya (USD)
2.47B / 2.51B
-1.75%kinulang
Earnings call para sa Fiscal Q2 2026
Hinihintay ang earnings call
Sa isang sulyap
Mga insight mula sa mga pinakabagong balita at ulat
Mga nakaraang ulatLahat ng value sa USD
Loading Previous Earnings...
Kita
Net na kita
Lahat ng value sa USD
Set 2025
Dis 2025
Mar 2026
Hun 2026
Kita
2.40B
2.39B
2.26B
2.47B
Gastusin sa mga naibentang produkto
682.00M
711.00M
640.00M
670.00M
Halaga ng kita
682.00M
711.00M
640.00M
670.00M
Mga gastos sa pananaliksik at pag-develop
170.00M
199.00M
180.00M
173.00M
Kabuuang gastos sa pananaliksik at pag-develop
-
-
-
-
Mga gastos sa pagbebenta, pangkalahatan, at admin
572.00M
618.00M
584.00M
589.00M
Gastos sa pagpapatakbo
774.00M
848.00M
795.00M
793.00M
Kabuuang gastos sa pagpapatakbo
1.46B
1.56B
1.44B
1.46B
Kita sa pagpapatakbo
944.00M
828.00M
827.00M
1.00B
Iba pang hindi kita sa pagpapatakbo
-
-6.00M
-1.00M
-2.00M
EBT na may mga hindi karaniwang item
887.00M
761.00M
758.00M
866.00M
EBT na hindi kasama ang mga hindi karaniwang item
899.00M
780.00M
779.00M
948.00M
Gastos sa buwis sa kita
166.00M
158.00M
157.00M
175.00M
Epektibong rate ng buwis
18.71%
20.76%
20.71%
20.21%
Iba pang gastos sa pagpapatakbo
-
-
-
-
Net na kita
721.00M
603.00M
601.00M
691.00M
Margin ng kabuuang kita
30.04%
25.26%
26.57%
28.00%
Kita bawat share
1.70
1.48
1.53
1.87
Kita sa interes at investment
26.00M
25.00M
21.00M
16.00M
Gastos sa interes
-58.00M
-57.00M
-62.00M
-61.00M
Mga net na gastos sa interes
-32.00M
-32.00M
-41.00M
-45.00M
Mga singil sa depreciation at amortization
-
-
-
-
EBITDA
1.07B
903.00M
946.00M
1.12B
Kita o pagkalugi mula sa pagbebenta ng mga asset
-
-
-6.00M
-1.00M
Mga transaksyon ng insider
Kinukuha ang data ng mga insider na transaksyon mula sa mga third-party na source. Matuto pa
Insider
Posisyon
Uri
Petsa
Mga Share
Halaga
Page 1
Posibleng magkaroon ng mga pagkakamali ang AI content. Matuto pa
Mga app ng Google